CheckMate 025: A randomized, open-label, phase Ill study of nivolumab versus everolimus in advanced renal cell carcinoma (RCC) Meeting Abstract
| Authors: | Motzer, R. J.; Escudier, B.; McDermott, D. F.; George, S.; Hammers, H. J.; Srinivas, S.; Tykodi, S. S.; Sosman, J. A.; Procopio, G.; Plimack, E. R.; Castellano, D.; Gurney, H.; Donskov, F.; Bono, P.; Wagstaff, J.; Gauler, T. C.; Ueda, T.; Xu, L. A.; Waxman, I. M.; Sharma, P.; On behalf of the CheckMate 025 Investigators |
| Abstract Title: | CheckMate 025: A randomized, open-label, phase Ill study of nivolumab versus everolimus in advanced renal cell carcinoma (RCC) |
| Meeting Title: | 14th International Kidney Cancer Symposium (IKCS) |
| Journal Title: | BJU International |
| Volume: | 116 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2015 Nov 6-7 |
| Meeting Location: | Miami, FL |
| ISSN: | 1464-4096 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2015-12-01 |
| Start Page: | 17 |
| Language: | English |
| ACCESSION: | WOS:000366284900033 |
| PROVIDER: | wos |
| PUBMED: | 26492557 |
| DOI: | 10.1111/bju.13365 |
| Notes: | Meeting Abstract -- 14th International Kidney Cancer Symposium -- NOV 06-07, 2015 -- Miami, FL -- SI -- Source: Wos |
